Authentikos Wealth Advisory’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-106
Closed -$34.2K 87
2024
Q3
$34.2K Buy
+106
New +$34.7K 0.03% 122
2023
Q4
Sell
-138
Closed -$37.1K 82
2023
Q3
$37.1K Buy
+138
New +$34.4K 0.04% 152

Other funds holding AMGN

Authentikos Wealth Advisory's AMGN Position: Q4 2024 in Review

Authentikos Wealth Advisory sold out of Amgen (AMGN) in Q4 2024, closing a stake of 106 shares — an estimated $34.2K sold.

Authentikos Wealth Advisory first reported a position in AMGN in Q3 2023 and held it in 2 quarters. The position peaked at $37.1K in Q3 2023. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Authentikos Wealth Advisory reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Authentikos Wealth Advisory sold 106 Amgen shares in Q4 2024, an estimated $34.2K.
  • Authentikos Wealth Advisory first reported a position in Amgen in Q3 2023 and held it in 2 quarters.
  • Authentikos Wealth Advisory's Amgen position peaked at $37.1K in Q3 2023.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Authentikos Wealth Advisory's 13F filing for Q4 2024, filed 29 Jan 2025.